Arxx Therapeutics Revenue
Biotechnology Research • 
Oslo, Oslo, Norway • 1-10 Employees
$
Arxx Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Arxx Therapeutics
Gunhild Klarskov Kristiansen
CMC Director
Company overview
| Headquarters | Oslo, Oslo, Norway |
| Websites | |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
About Arxx Therapeutics
Founded in 2018, Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
Arxx Therapeutics has never raised funding before.
Arxx Therapeutics Tech Stack
Discover the technologies and tools that power Arxx Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Form builders
Tag managers
JavaScript libraries
Reverse proxies
Programming languages
Miscellaneous
Blogs
JavaScript libraries
Performance
JavaScript libraries
Analytics
PaaS
United States
United Kingdom
Canada
IsraelFrequently asked questions
Arxx Therapeutics is located in Oslo, Oslo, NO.
Arxx Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
Arxx Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Arxx Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.
Arxx Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
